The Eaton Vance Tax-Managed Global Diversified Equity Income Fund (EXG) provides an 8.40% yield through a mix of global stocks and index call option writing. While its distributions are supported by realized gains, dividend income alone is not enough, indicating dependence on options and capital gains. Despite its global focus, 60% of its portfolio is invested in U.S. equities, exposing investors to U.S. market and technology sector risks. The fund trades at a 9.84% discount to its net asset value and charges a 1.06% expense ratio with consistent monthly payouts.
The Eaton Vance Tax-Managed Global Diversified Equity Income Fund (EXG) offers an 8.40% yield, with notable exposure to U.S. equities and technology risks. For readers following US stocks, here is Pluang's market snapshot as of Oct 28, 2026 23:11 WIB: out of 150 priced US stocks, 73 rose and 76 fell. Key movers include HOOD at USD 90.99 with a 1-day change of -3.78% and Pluang order activity of 5% Sell / 95% Buy, CGC at USD 0.66 down 3.55%, and ASX at USD 43.45 up 3.30% with 41% Sell / 59% Buy activity and a typical hold time of 49 days.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
